Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Christopher Lewis Stone currently holds 405,559 shares of PDL BIOPHARMA, INC. (PDLI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher Lewis Stone has been a net seller of PDLI stock. They have purchased $0 and sold $512.0K worth of shares.
Christopher Lewis Stone's most recent insider trade was on Dec 16, 2020, when they sold 200,000 shares at $2.56 per share.
Christopher Lewis Stone serves as Executive at PDL BIOPHARMA, INC. (PDLI). They have executed 20 insider transactions totaling $512.0K over their tenure at the company.
Christopher Lewis Stone holds the position of Executive at PDL BIOPHARMA, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 18 years and currently hold a stake valued at $0.
Christopher Lewis Stone has shown a selling trading pattern, with $0 in total purchases and $512.0K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Christopher Lewis Stone was on Dec 16, 2020, when they sold $512.0K worth of PDLI shares. This transaction involved 200,000 shares at $2.56 per share.
Christopher Lewis Stone currently owns 405,559 shares of PDL BIOPHARMA, INC. (PDLI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Christopher Lewis Stone's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Christopher Lewis Stone has 20 Form 4 filings on record as an insider at PDL BIOPHARMA, INC..
Set alerts for Christopher Lewis Stone and 40,000+ other insiders.